Dr Charlie McTernan
Senior Lecturer in Chemistry
Research interests
- Chemistry
Biography
Charlie is a Group Leader at the Francis Crick Institute, and a Senior Lecturer in Chemistry at King's. His research focuses on investigating how Artificial Molecular Machines and Metal-Organic Capsules can be applied in Biomedical Science.
He studied Chemistry at the University of Oxford. He joined Professor David Leigh’s group in 2013. His doctoral research included the synthesis of artificial molecular machines, switchable catalysts, and rotaxanes. In September 2017 he joined the Nitschke Group, and in September 2018 began his Leverhulme Early Career Research Fellowship, and joined Sidney Sussex College as a Research Fellow, where he investigated the synthesis and post-assembly modification of diverse metal-organic capsules, and ways to tie molecular knots in single molecules. In 2021, he started his independent career, exploring how interlocked architectures and metal-organic capsules can be applied in biological settings.
Research Interests
- Supramolecular Chemistry in Biological Setting
- Aims to apply recent breakthroughs in artificial molecular machines and metal-organic capsules in biologically relevant settings.
Research
The Francis Crick Institute
King’s is delighted to be a founding academic partner alongside UCL and Imperial College in the Francis Crick Institute, joining the multidisciplinary research expertise from all the Partners together to deliver world-leading biomedical research.
News
Inaugural 1851–Ramsay Research Fellow joins King's Chemistry
Dr Aisha N. Bismillah will be hosted by the McTernan Group to create light-activated mimics of enzymes to help deliver medicine.
Chicken feathers to deliver chemotherapy drugs and repair enzymes
An amino acid found in chicken feathers and skin tissue could be the key to limiting the side effects of chemotherapy.
King's Chemist to further drug discovery efforts by researching use of cyclic peptides to build new molecular machinery
It’s hoped that the new research could lead to the development of novel drug delivery systems and cancer treatments.
Research
The Francis Crick Institute
King’s is delighted to be a founding academic partner alongside UCL and Imperial College in the Francis Crick Institute, joining the multidisciplinary research expertise from all the Partners together to deliver world-leading biomedical research.
News
Inaugural 1851–Ramsay Research Fellow joins King's Chemistry
Dr Aisha N. Bismillah will be hosted by the McTernan Group to create light-activated mimics of enzymes to help deliver medicine.
Chicken feathers to deliver chemotherapy drugs and repair enzymes
An amino acid found in chicken feathers and skin tissue could be the key to limiting the side effects of chemotherapy.
King's Chemist to further drug discovery efforts by researching use of cyclic peptides to build new molecular machinery
It’s hoped that the new research could lead to the development of novel drug delivery systems and cancer treatments.